<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To assess potential differences in genetic predisposition to myeloid <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, we evaluated the karyotypes and reviewed results of cytogenetic studies on bone marrow specimens from six patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, or <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, and a history of <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumor</z:e> managed solely by surgical resection </plain></SENT>
<SENT sid="1" pm="."><plain>Structural or numerical deletions of chromosome 5 were identified in each of four patients with abnormal marrow karyotypes </plain></SENT>
<SENT sid="2" pm="."><plain>Constitutional karyotypes were <z:mpath ids='MPATH_458'>normal</z:mpath> in two patients studied with clonal marrow chromosome abnormalities </plain></SENT>
<SENT sid="3" pm="."><plain>Review of previously reported cases of myeloid <z:hpo ids='HP_0002664'>neoplasia</z:hpo> following resection of <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> disclosed a preponderance of chromosome 5 deletions </plain></SENT>
<SENT sid="4" pm="."><plain>Predisposition to specific chromosome loss may influence genetic expression of disease in <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumor</z:e> patients developing <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancy</z:e> </plain></SENT>
</text></document>